Conditionally replicating vectors and the parasitism of HIV-1
Conditionally replicating vectors and the parasitism of HIV-1
批准号:
9042225
负责人:
Boro Dropulic
金额:
$17.93万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
已结题
起止时间:
至 2018-03-31
关键词:
AddressAffectAntiviral AgentsCCR5 geneCD4 Positive T LymphocytesCellsChromatinComplexDrug resistanceEnvironmentEpigenetic ProcessEventEvolutionExcisionFrequenciesGene ExpressionGene TargetingGenesGenetic RecombinationGenetic TranscriptionGenomeGenomicsHIVHIV-1HIV-2HumanIMPDH2 geneInfectionLymphocyteMediatingNatural SelectionsOutcomePrisoner&aposs DilemmaPropertyQuality of lifeRNARecombinantsRecoverySerial PassageSmall RNASystemT-LymphocyteTechnologyTestingTherapeuticUntranslated RNAVariantViralViruscell typechemokineglobal healthimprovedmacrophageparasitismpressurepromoterreceptor expressionresistant strainvectorviral RNAviral fitnessviral resistance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
HIV-1 remains a constant threat to global health through its ability to integrate and persist in the genome of infected cells. Current therapeutic strategies effectively reduce HIV-1 replication and improve quality of life, however, existence of viral variants allows for the persistence and eventual recovery of pathogenic variants.
These variants are the inevitable outcome of the stable integration of HIV-1, which allows for the natural selection and evolution of drug resistant strains. Interestingly, integrated HIV can provide an ideal environment for the propagation and dissemination of conditionally replicating vectors. We have found that when conditionally replicating vectors contain antiviral genes expressing small non-coding RNAs targeted to
transcriptionally active regions of the LTR, an added long-term epigenetic mediated selective pressure is placed on the virus. The observed selective pressure correlates with both the persistence of the vector and significant transcriptional suppression of the virus resulting in reduced viral fitness. Moreover, we will utilize these validated small non-coding RNAs and a recently developed small RNA targeted gene excision
complex to excise fragments of HIV-1 or CCR5 from human cells in an effort to permanently alter viral and OCRS co-receptor expression. In this project we will develop conditionally replicating vectors that can both target HIV-1 or CCR5 for suppression and/or excision while simultaneously hijacking the viral machinery to
spread the anti-HIV-1 vector to other cells being infected with HIV-1. In essence we wish to place a prisoners dilemma on HIV-1 and modulate viral fitness (Morris 2004; Morris and Looney 2005). We hypothesize that the observed long-term suppression of HIV-1 can be directly regulated by such selective pressures and propose to test this hypothesis by (1) utilizing selectable conditionally replicating HIV-2 vectors, (2) determining the best suppressive vector and whether the number of small RNAs targeted to HIV or CCR5 and/or the targeted loci is important and (3) characterizing the respective long-term suppressive and/or excision properties of the best candidate vectors in human T cells and macrophages.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Method of Generating Hepatitis C Virus-Like Particles using Lentivirus
-
批准号:7748047
-
项目类别:
-
资助金额:$28.29万
-
财政年份:2009
-
负责人:Boro Dropulic
-
依托单位:
Lentiviral expressed growth factors as a novel therapy in wound healing
-
批准号:7481788
-
项目类别:
-
资助金额:$11.91万
-
财政年份:2008
-
负责人:Boro Dropulic
-
依托单位:
T cell receptor gene vectors for EBV disease
-
批准号:7327262
-
项目类别:
-
资助金额:$13.41万
-
财政年份:2007
-
负责人:Boro Dropulic
-
依托单位:
Lentiviral Vectors for TCR Immunotherapy Targeted to HCV
-
批准号:7224649
-
项目类别:
-
资助金额:$28.97万
-
财政年份:2007
-
负责人:Boro Dropulic
-
依托单位:
Immunotherapy of CLL with lentiviral expressed CD40-ligand
-
批准号:7161658
-
项目类别:
-
资助金额:$11.46万
-
财政年份:2006
-
负责人:Boro Dropulic
-
依托单位:
Clinical Vector for TCR Immunotherapy Targeted to Melanoma
-
批准号:7914960
-
项目类别:
-
资助金额:$119.18万
-
财政年份:2006
-
负责人:Boro Dropulic
-
依托单位:
Clinical Vector for TCR Immunotherapy Targeted to Melanoma
-
批准号:8092817
-
项目类别:
-
资助金额:$216.08万
-
财政年份:2006
-
负责人:Boro Dropulic
-
依托单位:
Lentiviral Vectors for TCR Immunotherapy Targeted to melanoma
-
批准号:7224655
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2006
-
负责人:Boro Dropulic
-
依托单位:
Clinical Vector for TCR Immunotherapy Targeted to Melanoma
-
批准号:8296053
-
项目类别:
-
资助金额:$172.98万
-
财政年份:2006
-
负责人:Boro Dropulic
-
依托单位:
Lentiviral engineered T cell immunotherapy in tumors overexpressing mesothelin
-
批准号:7161656
-
项目类别:
-
资助金额:$23.66万
-
财政年份:2006
-
负责人:Boro Dropulic
-
依托单位:
cGMP and cGLP Lentiviral Vetors
-
批准号:6998379
-
项目类别:
-
资助金额:$11.07万
-
财政年份:2005
-
负责人:Boro Dropulic
-
依托单位:
HIV-1 vector mediated gene therapy for HIV-1 infection
-
批准号:6484538
-
项目类别:
-
资助金额:$28.15万
-
财政年份:2002
-
负责人:Boro Dropulic
-
依托单位:
HIV-1 vector mediated gene therapy for HIV-1 infection
-
批准号:6745806
-
项目类别:
-
资助金额:$49.86万
-
财政年份:2002
-
负责人:Boro Dropulic
-
依托单位:
NOVEL HIV VECTORS MIMIC NATURAL ANTIHIV RESPONSES
-
批准号:2673189
-
项目类别:
-
资助金额:$24.3万
-
财政年份:1997
-
负责人:Boro Dropulic
-
依托单位:
NOVEL HIV VECTORS MIMIC NATURAL ANTIHIV RESPONSES
-
批准号:2555197
-
项目类别:
-
资助金额:$23.81万
-
财政年份:1997
-
负责人:Boro Dropulic
-
依托单位:
cGMP and cGLP Lentiviral Vetors
-
批准号:7549278
-
项目类别:
-
资助金额:$19.39万
-
财政年份:--
-
负责人:Boro Dropulic
-
依托单位:
Conditionally replicating vectors and the parasitism of HIV-1
-
批准号:8311227
-
项目类别:
-
资助金额:$28.61万
-
财政年份:--
-
负责人:Boro Dropulic
-
依托单位:
Conditionally replicating vectors and the parasitism of HIV-1
-
批准号:8637919
-
项目类别:
-
资助金额:$44.85万
-
财政年份:--
-
负责人:Boro Dropulic
-
依托单位:
cGMP and cGLP Lentiviral Vetors
-
批准号:7549272
-
项目类别:
-
资助金额:$24.13万
-
财政年份:--
-
负责人:Boro Dropulic
-
依托单位:
Conditionally replicating vectors and the parasitism of HIV-1
-
批准号:8451988
-
项目类别:
-
资助金额:$37.92万
-
财政年份:--
-
负责人:Boro Dropulic
-
依托单位:
海外基金